CRBP Corbus Pharmaceuticals Holdings, Inc.

Fundamentals / CIK 0001595097 / USD

Corbus Pharmaceuticals Holdings, Inc. reported $122.9M in total assets and a net loss of $116.3M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRBP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$47.37M$23.69M$0-$107.1MFY 2016 Revenue: $1.91MFY 2016 Net Income: -$20.00M2016FY 2017 Revenue: $2.44MFY 2017 Net Income: -$32.42M2017FY 2018 Revenue: $4.82MFY 2018 Net Income: -$55.67M2018FY 2019 Revenue: $36.14MFY 2019 Net Income: -$71.45M2019FY 2020 Revenue: $3.94MFY 2020 Net Income: -$111.3M2020FY 2021 Revenue: $882KFY 2021 Net Income: -$45.64M2021FY 2022 Revenue: $0FY 2022 Net Income: -$42.35M2022FY 2023 Net Income: -$44.60M2023FY 2024 Net Income: -$40.21M2024FY 2025 Net Income: -$78.54M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $0 $882K $3.94M $36.14M $4.82M $2.44M $1.91M
Research & Development $70.09M $32.22M $31.17M $16.14M $36.45M $98.27M $89.60M $48.61M $26.04M $15.44M
Total Operating Expenses $85.31M $48.72M $45.08M $39.84M $56.87M $126.7M $113.2M $61.57M $35.00M $21.90M
Operating Income -$85.31M -$48.72M -$45.08M -$39.84M -$55.99M -$122.8M -$77.10M -$56.75M -$32.56M -$19.99M
EBITDA -$85.08M -$48.13M -$44.44M -$39.07M -$54.99M -$121.7M -$76.37M -$56.25M -$32.31M -$19.90M
Interest Income -- -- -- -- -- -- $1.23M $983K -- --
Interest Expense $0 $1.87M $3.86M $3.10M $2.71M $1.13M $0 -- $3.6K $3.1K
Income Tax Expense $0 $0 -- -- -- -- -- -- -- --
Net Income -$78.54M -$40.21M -$44.60M -$42.35M -$45.64M -$111.3M -$71.45M -$55.67M -$32.42M -$20.00M
Basic EPS -$5.90 -$3.68 -$10.31 -$10.15 -$11.15 -$42.64 -$33.63 -$29.43 -$19.52 -$14.71
Diluted EPS -$5.90 -$3.68 -$10.31 -$10.15 -$11.15 -$42.64 -$33.63 -$29.43 -$19.52 -$14.71
Basic Shares Outstanding 13.3M 10.9M 4.3M 4.2M 4.1M 2.6M 2.1M 1.9M 1.7M 1.4M
Diluted Shares Outstanding 13.3M 10.9M 4.3M 4.2M 4.1M 2.6M 2.1M 1.9M 1.7M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $34.25M $31.18M $19.82M $18.41M $20.86M $15.19M $15.64M $8.79M
Total Operating Expenses $38.82M $36.19M $24.30M $21.97M $24.42M $19.15M $19.77M $12.61M
Operating Income -$38.82M -$36.19M -$24.30M -$21.97M -$24.42M -$19.15M -$19.77M -$12.61M
EBITDA -$38.77M -$36.14M -$24.25M -$21.92M -$24.37M -$19.10M -$19.69M -$12.47M
Interest Expense -- -- -- $0 $0 $0 $0 $0
Net Income -$37.75M -$35.04M -$22.97M -$20.55M -$23.34M -$17.66M -$16.98M -$9.53M
Basic EPS -$1.81 -$1.81 -$1.23 -- -$1.90 -$1.44 -$1.39 --
Diluted EPS -$1.81 -$1.81 -$1.23 -- -$1.90 -$1.44 -$1.39 --
Basic Shares Outstanding 20.8M 19.4M 18.7M -- 12.3M 12.2M 12.2M --
Diluted Shares Outstanding 20.8M 19.4M 18.7M -- 12.3M 12.2M 12.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $28.49M $17.20M $13.72M $17.00M $25.01M $85.43M $31.75M $41.75M $62.54M $14.99M
Short-Term Investments $134.8M $131.9M $7.18M $42.19M $72.64M -- -- -- -- --
Cash & Short-Term Investments $163.3M $149.1M $20.91M $59.20M $97.65M $85.43M $31.75M $41.75M $62.54M $14.99M
Total Current Assets $167.0M $153.0M $23.55M $60.18M $100.2M $92.07M $38.15M $44.24M $65.50M $17.40M
Property, Plant & Equipment, Net $159K $385K $973K $1.61M $2.39M $4.07M $5.08M $2.71M $1.43M $435K
Other Non-Current Assets -- $0 $212K $155K $46K $234K $85K $44K $41K --
Total Non-Current Assets $1.24M $2.90M $4.73M $6.13M $7.53M $10.22M $10.99M $2.75M $1.47M $485K
Total Assets $168.2M $155.9M $28.27M $66.31M $107.7M $102.3M $49.14M $46.99M $66.98M $17.89M
Accounts Payable $2.21M $4.79M $3.18M $2.17M $1.78M $7.38M $11.09M $6.35M $3.13M $3.42M
Short-Term Debt -- -- $15.91M $2.80M $3.09M -- -- -- -- --
Deferred Revenue (Current) -- -- -- -- -- -- -- $1.46M -- $1.94M
Total Current Liabilities $20.69M $11.82M $31.89M $12.64M $17.01M $31.90M $34.89M $18.09M $8.20M $8.90M
Long-Term Debt -- -- $0 $15.98M $15.64M $18.03M -- -- -- --
Other Non-Current Liabilities -- $0 $44K $22K $22K -- -- -- $375 $4.6K
Total Non-Current Liabilities $0 $1.63M $3.28M $20.68M $21.61M $25.12M $8.10M $1.38M $990K $70K
Total Liabilities $20.69M $13.45M $35.18M $33.32M $38.62M $57.02M $42.98M $19.47M $9.19M $8.97M
Total Debt (incl. Leases) $1.63M $3.24M $20.58M $24.74M $25.82M $26.13M $8.69M $1.41M -- --
Common Stock $2.0K $1.0K $0 $417 $416 $9.9K $6.5K $5.7K $5.6K $4.5K
Retained Earnings -$555.4M -$476.9M -$436.7M -$392.1M -$349.7M -$304.1M -$192.8M -$121.4M -$65.70M -$33.28M
Accumulated Other Comp. Income -$53K $35K -$1.0K -$126K -$62K -- -- -- -- --
Total Stockholders' Equity $147.5M $142.4M -$6.91M $32.99M $69.11M $45.27M $6.16M $27.52M $57.78M $8.92M
Total Equity $147.5M $142.4M -$6.91M $32.99M $69.11M $45.27M $6.16M $27.52M $57.78M $8.92M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $30.25M $23.37M $25.66M $28.49M $26.98M $20.04M $18.90M $17.20M
Short-Term Investments $85.09M $94.57M $112.6M $134.8M $77.00M $96.55M $113.9M $131.9M
Cash & Short-Term Investments $115.3M $117.9M $138.2M $163.3M $104.0M $116.6M $132.8M $149.1M
Total Current Assets $119.0M $122.8M $143.6M $167.0M $107.6M $122.8M $137.4M $153.0M
Property, Plant & Equipment, Net $36K $71K $116K $159K $201K $251K $304K $385K
Other Non-Current Assets -- -- -- -- -- -- -- $0
Total Non-Current Assets $3.95M $4.24M $914K $1.24M $1.94M $2.26M $2.57M $2.90M
Total Assets $122.9M $127.0M $144.5M $168.2M $109.5M $125.1M $139.9M $155.9M
Accounts Payable $4.07M $5.25M $435K $2.21M $2.74M $3.99M $4.07M $4.79M
Total Current Liabilities $34.97M $21.48M $18.14M $20.69M $17.06M $13.33M $11.62M $11.82M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $3.18M $3.27M $0 $0 $307K $761K $1.21M $1.63M
Total Liabilities $38.14M $24.75M $18.14M $20.69M $17.37M $14.09M $12.82M $13.45M
Total Debt (incl. Leases) $3.91M $4.26M $1.21M $1.63M $2.05M $2.46M $2.85M $3.24M
Common Stock $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$651.2M -$613.4M -$578.4M -$555.4M -$534.9M -$511.5M -$493.9M -$476.9M
Accumulated Other Comp. Income -$196K -$107K -$161K -$53K -$3.0K -$39K -$23K $35K
Total Stockholders' Equity $84.76M $102.2M $126.3M $147.5M $92.15M $111.0M $127.1M $142.4M
Total Equity $84.76M $102.2M $126.3M $147.5M $92.15M $111.0M $127.1M $142.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$78.54M -$40.21M -$44.60M -$42.35M -$45.64M -$111.3M -$71.45M -$55.67M -$32.42M -$20.00M
Depreciation & Amortization $233K $588K $641K $763K $1000K $1.12M $739K $494K $256K $88K
Stock-Based Compensation $6.29M $6.14M $3.47M $5.72M $9.48M $12.46M $11.98M $7.61M $5.69M $3.16M
Change in Receivables -- -- -- -- -- -- $5.00M $12.50M $1.00M -$1.00M
Change in Payables -$2.35M $1.60M $1.03M -$257K -$5.96M -$3.47M $4.37M $3.90M -$886K $1.89M
Operating Cash Flow -$64.49M -$41.79M -$36.10M -$37.54M -$48.18M -$99.69M -$45.72M -$30.07M -$27.80M -$13.57M
Capital Expenditure -$7.0K $0 $0 -$13K -$54K -$484K -$2.74M -$2.30M -$707K -$353K
Free Cash Flow -$64.50M -$41.79M -$36.10M -$37.56M -$48.24M -$100.2M -$48.46M -$32.37M -$28.50M -$13.92M
Purchases of Investments -$163.1M -$180.8M -$33.88M -$86.34M -$87.27M -- -- -- -- --
Sales & Maturities of Investments $161.5M $59.49M $69.53M $116.4M $13.88M -- -- -- -- --
Investing Cash Flow -$1.64M -$121.3M $35.64M $30.07M -$73.42M -$484K -$2.74M -$2.30M -$707K -$353K
Common Stock Issued $77.43M $182.1M $53K -- $62.59M $142.2M $40.68M $12.05M $78.89M $16.70M
Financing Cash Flow $77.43M $166.6M -$2.82M -$534K $60.82M $154.9M $38.46M $11.42M $76.01M $16.74M
Net Change in Cash $11.29M $3.47M -$3.28M -$8.00M -$60.78M $54.70M -$10.00M -$20.95M $47.50M $2.82M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$37.75M -$35.04M -$22.97M -$20.55M -$23.34M -$17.66M -$16.98M -$9.53M
Depreciation & Amortization $50K $51K $49K $49K $50K $53K $81K $134K
Stock-Based Compensation $1.81M $1.81M $1.92M $1.43M $1.58M $1.56M $1.71M $1.63M
Change in Payables -$1.19M $4.81M -$1.87M -$564K -$1.28M $175K -$684K $1.68M
Operating Cash Flow -$21.24M -$29.63M -$25.57M -$15.92M -$15.55M -$16.60M -$16.42M -$10.94M
Capital Expenditure -$15K -$6.0K -$6.0K -$7.0K $0 $0 $0 --
Free Cash Flow -$21.25M -$29.63M -$25.58M -$15.93M -$15.55M -$16.60M -$16.42M --
Purchases of Investments -$43.92M -$8.70M -$10.73M -$90.02M -$17.84M -$17.62M -$37.60M -$11.24M
Sales & Maturities of Investments $53.49M $26.96M $33.19M $32.88M $37.48M $35.37M $55.73M $19.97M
Investing Cash Flow $9.56M $18.26M $22.45M -$57.15M $19.64M $17.74M $18.12M $8.73M
Common Stock Issued -- -- -- $74.58M $2.85M $0 $0 -$13K
Financing Cash Flow -- -- -- $74.58M $2.85M $0 $0 -$13K
Net Change in Cash $6.88M -$2.29M -$3.12M $1.51M $6.94M $1.14M $1.70M -$2.23M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -6350.1% -3119.2% -213.3% -1176.8% -1334.4% -1045.6%
Net Profit Margin -- -- -- -- -5176.4% -2826.1% -197.7% -1154.5% -1328.6% -1046.3%
Return on Equity (ROE) -53.2% -28.2% -- -128.4% -66.0% -245.8% -1160.4% -202.3% -56.1% -224.2%
Return on Assets (ROA) -46.7% -25.8% -157.8% -63.9% -42.4% -108.8% -145.4% -118.5% -48.4% -111.8%
Current Ratio 8.07x 12.94x 0.74x 4.76x 5.89x 2.89x 1.09x 2.45x 7.98x 1.96x
Quick Ratio 7.89x 12.61x 0.66x 4.68x 5.74x 2.68x 0.91x 2.31x 7.62x 1.68x
Debt to Equity 0.01x 0.02x -- 0.75x 0.37x 0.58x 1.41x 0.05x -- --
Revenue Growth (YoY) -- -- -- -100.0% -77.6% -89.1% +649.5% +97.6% +27.7% +194.8%
5Y Revenue / Share Growth -- -- -- -100.0% -84.6% +143.6% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -137.2% -99.7% -66.9% -53.2% -73.3% -52.2% -39.6% -28.2%
Return on Assets (ROA) -94.6% -80.2% -58.5% -46.7% -61.6% -46.3% -35.9% -25.8%
Current Ratio 3.40x 5.71x 7.92x 8.07x 6.31x 9.21x 11.82x 12.94x
Quick Ratio 3.30x 5.49x 7.62x 7.89x 6.10x 8.74x 11.43x 12.61x
Debt to Equity 0.05x 0.04x 0.01x 0.01x 0.02x 0.02x 0.02x 0.02x
Source: SEC EDGAR CompanyFacts (CIK 0001595097) · from September 30, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal